Op/Ed: Rethinking R&D Tax Relief–Why Smarter Incentives Are Key to Unlocking UK Pharma Innovation
ByAna Ali
UK pharma small- and medium-sized enterprises face funding and R&D barriers. Improved tax relief and targeted incentives are vital to keep UK innovation competitive.
